Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burcu Isler

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2026
Possible quality indicators for clinical infectious diseases consultations - results from a hybrid Delphi-nominal group approach and scenario studyDaniel Hornuss, Philipp Mathé, Roland Giesen, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2026
Management and follow-up of patients with infective endocarditis: an international cross-sectional surveyLaura Escolà-Vergé, Philipp Mathé, Burcu Isler, et al.
Microorganisms|July 27, 2022
<i>Achromobacter</i> Species: An Emerging Cause of Community-Onset Bloodstream InfectionsBurcu Isler, David L Paterson, Patrick N A Harris, et al.
Clinical Microbiology Reviews|October 9, 2025
Current and future options for the treatment of serious infections due to carbapenem-resistant <i>Pseudomonas aeruginosa</i>Juan P Horcajada, Ana C Gales, Burcu Isler, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 25, 2025
How do I manage Difficult-to-Treat Pseudomonas aeruginosa infections?: Key Questions for Today's CliniciansJuan P Horcajada, Ana Gales, Burcu Isler, et al.
Journal of Medical Microbiology|February 7, 2023
High prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant <i>Klebsiella pneumoniae</i> bloodstream isolatesBurcu Isler, Caitlin Falconer, Cansel Vatansever, et al.
Infectious Diseases (London, England)|July 1, 2023
Higher rates of cefiderocol resistance among NDM producing <i>Klebsiella</i> bloodstream isolates applying EUCAST over CLSI breakpointsBurcu Isler, Cansel Vatansever, Berna Özer, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 18, 2022
Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic settingBurcu Isler, Berna Özer, Güle Çınar, et al.
Diagnostic Microbiology and Infectious Disease|July 17, 2022
Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolatesBurcu Isler, Cansel Vatansever, Berna Özer, et al.
BMJ Open|May 27, 2019
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with <i>Pseudomonas aeruginosa</i> bacteraemia (IRONIC study): study protocol of a retrospective multicentre international studyAdaia Albasanz-Puig, Carlota Gudiol, Rocío Parody, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2026
Possible quality indicators for clinical infectious diseases consultations - results from a hybrid Delphi-nominal group approach and scenario studyDaniel Hornuss, Philipp Mathé, Roland Giesen, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2026
Management and follow-up of patients with infective endocarditis: an international cross-sectional surveyLaura Escolà-Vergé, Philipp Mathé, Burcu Isler, et al.
Microorganisms|July 27, 2022
<i>Achromobacter</i> Species: An Emerging Cause of Community-Onset Bloodstream InfectionsBurcu Isler, David L Paterson, Patrick N A Harris, et al.
Clinical Microbiology Reviews|October 9, 2025
Current and future options for the treatment of serious infections due to carbapenem-resistant <i>Pseudomonas aeruginosa</i>Juan P Horcajada, Ana C Gales, Burcu Isler, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 25, 2025
How do I manage Difficult-to-Treat Pseudomonas aeruginosa infections?: Key Questions for Today's CliniciansJuan P Horcajada, Ana Gales, Burcu Isler, et al.
Journal of Medical Microbiology|February 7, 2023
High prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant <i>Klebsiella pneumoniae</i> bloodstream isolatesBurcu Isler, Caitlin Falconer, Cansel Vatansever, et al.
Infectious Diseases (London, England)|July 1, 2023
Higher rates of cefiderocol resistance among NDM producing <i>Klebsiella</i> bloodstream isolates applying EUCAST over CLSI breakpointsBurcu Isler, Cansel Vatansever, Berna Özer, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 18, 2022
Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic settingBurcu Isler, Berna Özer, Güle Çınar, et al.
Diagnostic Microbiology and Infectious Disease|July 17, 2022
Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolatesBurcu Isler, Cansel Vatansever, Berna Özer, et al.
BMJ Open|May 27, 2019
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with <i>Pseudomonas aeruginosa</i> bacteraemia (IRONIC study): study protocol of a retrospective multicentre international studyAdaia Albasanz-Puig, Carlota Gudiol, Rocío Parody, et al.
Pageof 4